Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximab Clinical Trials

1 actively recruiting trial

Also known as: Systemic therapy including PD-1 inhibitor

Filter by location:

Other1 trial

A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.